Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Science Advances
|
November 24, 2023
Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer
Sujin Hyung, Jihoon Ko, You Jeong Heo, et al.
ACS Applied Materials & Interfaces
|
April 14, 2021
Rapid Visual Authentication Based on DNA Strand Displacement
Kimberly L Berk, Steven M Blum, Vanessa L Funk, et al.
ACS Synthetic Biology
|
April 12, 2021
Impact of Porous Matrices and Concentration by Lyophilization on Cell-Free Expression
Steven M Blum, Marilyn S Lee, Glory E Mgboji, et al.
Journal of the American Academy of Dermatology
|
February 22, 2022
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma
Maria S Asdourian, Tracey S Otto, Ted V Jacoby, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2025
Tumor location as a risk factor for severe immune-related adverse events
Steven M Blum, Ben Ouyang, Leyre Zubiri, et al.
Cancer
|
June 23, 2020
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis
Shilpa Grover, Michael Dougan, Kevin Tyan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 4, 2016
Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer
Tanya Stoyanova, Mireille Riedinger, Shu Lin, et al.
ACS Synthetic Biology
|
March 12, 2025
Semiautomated Production of Cell-Free Biosensors
Dylan M Brown, Daniel A Phillips, David C Garcia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 21, 2023
Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
Selina K Wong, Steven M Blum, Xiaopeng Sun, et al.
Journal for Immunotherapy of Cancer
|
September 21, 2021
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
Leyre Zubiri, Gabriel E Molina, Meghan J Mooradian, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Science Advances
|
November 24, 2023
Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer
Sujin Hyung, Jihoon Ko, You Jeong Heo, et al.
ACS Applied Materials & Interfaces
|
April 14, 2021
Rapid Visual Authentication Based on DNA Strand Displacement
Kimberly L Berk, Steven M Blum, Vanessa L Funk, et al.
ACS Synthetic Biology
|
April 12, 2021
Impact of Porous Matrices and Concentration by Lyophilization on Cell-Free Expression
Steven M Blum, Marilyn S Lee, Glory E Mgboji, et al.
Journal of the American Academy of Dermatology
|
February 22, 2022
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma
Maria S Asdourian, Tracey S Otto, Ted V Jacoby, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2025
Tumor location as a risk factor for severe immune-related adverse events
Steven M Blum, Ben Ouyang, Leyre Zubiri, et al.
Cancer
|
June 23, 2020
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis
Shilpa Grover, Michael Dougan, Kevin Tyan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 4, 2016
Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer
Tanya Stoyanova, Mireille Riedinger, Shu Lin, et al.
ACS Synthetic Biology
|
March 12, 2025
Semiautomated Production of Cell-Free Biosensors
Dylan M Brown, Daniel A Phillips, David C Garcia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 21, 2023
Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
Selina K Wong, Steven M Blum, Xiaopeng Sun, et al.
Journal for Immunotherapy of Cancer
|
September 21, 2021
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
Leyre Zubiri, Gabriel E Molina, Meghan J Mooradian, et al.
Page
of 3